Americans are increasingly concerned that regulators and manufacturers will rush a vaccine to market without an adequate review.
That prompted nine vaccine front-runners, including Pfizer and Merck, to...
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok